Study to Evaluate the Effect of Aficamten Administration on QT/QTc Interval
Clinical trial NCT05924815 · COMPLETED
Trial details
- NCT number
- NCT05924815
- Sponsor
- Cytokinetics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2023-11-14
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.